• Return to Headlines

Lowest Return on Equity in the Biotechnology Industry Detected in Shares of Array Biopharma (ARRY, CHRS, KERX, BCRX, NVAX)

By Nick Russo

Below are the three companies in the Biotechnology industry with the lowest return on equity. The ROE is a general indication of the company's efficiency; investors usually look for companies with ROEs that are high and are growing.

Array Biopharma ranks lowest with a ROE of -34,388.0%. Following is Charming Shoppes with a ROE of -28,268.0%. Keryx Biopharmaceuticals ranks third lowest with a ROE of -23,080.7%.

BioCryst Pharmaceuticals follows with a ROE of -20,216.9%, and Novavax rounds out the bottom five with a ROE of -14,475.2%.

SmarTrend recommended that its subscribers protect gains by selling shares of BioCryst Pharmaceuticals on April 6th, 2017 by issuing a Downtrend alert when the shares were trading at $7.46. Since that call, shares of BioCryst Pharmaceuticals have fallen 26.5%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: lowest return on equity Array BioPharma amex:chrs charming shoppes keryx biopharmaceuticals biocryst pharmaceuticals Novavax

Ticker(s): ARRY KERX BCRX NVAX